文献速递运动医学关节外科

聚氨酯半月板支架治疗部分半月板缺损的5年随访:欧洲多中心研究

Polyurethane Meniscal Scaffold for the Treatment of Partial Meniscal Deficiency: 5-Year Follow-up Outcomes: A European Multicentric Study.
PubMed 文献 · Am J Sports Med · 2020-04-08

这项前瞻性单臂多中心病例系列研究纳入155例症状性部分半月板缺损患者(内侧101例、外侧54例),植入聚氨酯支架并随访至少5年。结果显示患者临床评分显著改善(P=.01),但2至5年间改善趋于稳定;5年时87.6%的植入物存活,内侧支架存活率87.9%、外侧86.9%,MRI显示多数支架较原生半月板体积小且表面不规则。

要点

  • 聚氨酯半月板支架可改善部分半月板缺损患者的膝关节功能并减轻疼痛,疗效维持5年。
  • 5年植入物总存活率为87.6%,内侧支架87.9%、外侧支架86.9%。
  • MRI显示5年时多数支架较原生半月板体积小且表面不规则。

核心结论

  • 聚氨酯半月板植入物能在植入后5年内改善节段性半月板缺损患者的膝关节功能并减轻疼痛。

研究设计与样本

  • 前瞻性单臂多中心病例系列研究,证据等级4级,纳入155例症状性部分半月板缺损患者(内侧101例、外侧54例),随访至少5年。

主要发现

  • 患者术后各临床评分显著改善(P=.01),但改善在2至5年随访间趋于稳定。
  • 5年随访时87.6%的植入物存活,内侧支架存活率87.9%、外侧支架86.9%。
  • 56例患者的MRI显示多数支架较原生半月板体积小且表面不规则。
  • 共23例治疗失败:10例因支架断裂取出、7例转为半月板同种异体移植、4例转为单髁膝关节置换、2例转为全膝关节置换。

关键数值与推荐

  • 临床结局采用疼痛视觉模拟量表、国际膝关节文献委员会主观膝关节评估表、Lysholm膝关节量表及膝关节损伤与骨关节炎结局评分评估。
  • 以支架取出、转为半月板移植及单髁/全膝关节置换为终点进行Kaplan-Meier生存分析。

临床怎么用

  • 对于症状性部分半月板缺损患者,聚氨酯支架可作为改善功能和减轻疼痛的治疗选择,但需告知5年存活率约87.6%及MRI下支架形态与原生半月板不同。

局限性

  • 本研究为单臂病例系列,证据等级4级,无对照组。
  • MRI评估仅基于56例患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A biodegradable polyurethane scaffold was developed to treat patients with the challenging clinical condition of painful partial meniscal defects. HYPOTHESIS: The use of an acellular polyurethane scaffold in patients with symptomatic partial meniscal defects would result in both midterm pain relief and improved function. STUDY DESIGN: Case series; Level of evidence, 4. METHODS: A total of 155 patients with symptomatic partial meniscal defects (101 medial and 54 lateral) were implanted with a polyurethane scaffold in a prospective, single-arm, multicentric study with a minimum 5-year follow-up. Clinical outcomes were measured with the visual analog scale for pain, International Knee Documentation Committee subjective knee evaluation form, Lysholm knee scale, and Knee injury and Osteoarthritis Outcome Score at baseline and at 2- and 5-year follow-ups. Magnetic resonance imaging (MRI) was used to evaluate the knee joint, meniscal implant, and meniscal extrusion. Kaplan-Meier survival analysis was also performed. Removal of the scaffold, conversion to a meniscal transplant, and unicompartmental/total knee arthroplasty were used as endpoints. RESULTS: Eighteen patients were lost to follow-up (11.6%). The patients who were included in this study showed significant clinical improvement after surgery as indicated by the different outcome measures (P = .01). However, the clinical improvement tended to stabilize between 2 and 5 years of follow-up. MRI scans of the scaffolds in 56 patients showed a smaller-sized implant in the majority of the cases when compared with the native meniscus with an irregular surface at the 5-year follow-up. During the follow-up period, 87.6% of the implants survived in this study. At 5 years of follow-up, 87.9% of the medial scaffolds were still functioning versus 86.9% of the lateral scaffolds. In total, 23 treatments had failed: 10 removed scaffolds because of breakage, 7 conversions to meniscal allograft transplantation, 4 conversions to unicompartmental knee arthroplasty, and 2 conversions to total knee arthroplasty. CONCLUSION: The polyurethane meniscal implant was able to improve knee joint function and reduce pain in patients with segmental meniscal deficiency over 5 years after implantation. The MRI appearance of this scaffold was different from the original meniscal tissue at the midterm follow-up. The treatment survival rates of 87.9% of the medial scaffolds and 86.9% of the lateral scaffolds in the present study compared favorably with those published concerning meniscal allograft transplantation after total meniscectomy.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Toanen C, Dhollander A, Bulgheroni P, et al. Polyurethane Meniscal Scaffold for the Treatment of Partial Meniscal Deficiency: 5-Year Follow-up Outcomes: A European Multicentric Study. Am J Sports Med. 2020. PMID: 32267737. doi:10.1177/0363546520913528

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。